Tatva Chintan Pharma Chem Share Price
Tatva Chintan Pharma Chem Share Price Today
As of 5 Jul 2026, Tatva Chintan Pharma Chem share price is ₹1,245.00. The stock opened at ₹1,280.00, compared to its previous close of ₹1,267.60. During today's trading session, Tatva Chintan Pharma Chem share price moved in the range of ₹1,245.00 to ₹1,280.00, with an average price of ₹1,262.50 for the day. Looking at its last 52-week, the stock has touched a low of ₹919.75 and a high of ₹1,610.00. On the performance front, Tatva Chintan Pharma Chem share price has declined by 10.02% over the last six months and is up 22.77% on a year-on-year basis.
Tatva Chintan Pharma Chem Returns Calculator
Tatva Chintan Pharma Chem Shareholder Returns
Tatva Chintan Pharma Chem Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Pidilite Industries | 1,63,368.00 | 66.11 | 15.08 | 22.61% | 0.03 | 29.97% | 104.79 | 1.34% | 1.18 | 23.43 |
| SRF | 82,964.90 | 39.50 | 5.16 | 13.76% | 0.28 | 13.78% | 5.73 | 0.37% | 0.78 | 58.18 |
| Linde India | 61,370.10 | 111.80 | 14.38 | 12.87% | 0.02 | 17.16% | 495.72 | 0.17% | 0.56 | 64.59 |
| Gujarat Fluorochemicals | 43,636.80 | 76.03 | 5.58 | 7.30% | 0.22 | 8.93% | 647.24 | 0.08% | 0.59 | 61.69 |
| Godrej Industries | 40,773.60 | 16.91 | 3.65 | 11.10% | 6.25 | 9.34% | 52.53 | 0.00% | 0.73 | 1.81 |
| Navin Fluorine | 39,211.90 | 59.10 | 9.87 | 16.69% | 0.03 | 18.14% | 714.61 | 0.20% | 0.60 | 96.03 |
| Himadri Speciality Chemicals | 33,428.40 | 29.64 | 4.73 | 17.92% | 0.12 | 22.34% | 4.82 | 0.18% | 0.89 | 15.05 |
| Deepak Nitrite | 21,438.30 | 38.93 | 3.67 | 9.43% | 0.02 | 10.74% | 235.74 | 0.48% | 0.79 | 13.85 |
| Deepak Fertilizers & Petr | 20,963.10 | 28.38 | 3.06 | 10.77% | 0.23 | 10.76% | 290.01 | 0.60% | 0.44 | 21.33 |
| Atul | 19,031.20 | 27.61 | 3.06 | 10.90% | 0.00 | 14.31% | 2,056.91 | 0.46% | 0.89 | 202.11 |
Tatva Chintan Pharma Chem Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹382.71 | ₹393.50 | ₹423.61 | ₹433.65 |
| Other Income | ₹2.32 | ₹7.51 | ₹5.74 | ₹8.89 |
| Total Revenue | ₹385.03 | ₹401.01 | ₹429.36 | ₹442.54 |
| Total Expenses | ₹377.45 | ₹357.45 | ₹380.99 | ₹338.42 |
| Profit Before Tax | ₹7.58 | ₹43.57 | ₹44.78 | ₹104.12 |
| Tax | ₹1.87 | ₹13.21 | -₹0.71 | ₹8.25 |
| Profit After Tax | ₹5.71 | ₹30.35 | ₹45.49 | ₹95.87 |
| EPS - Basic | ₹2.44 | ₹13.26 | ₹20.52 | ₹44.59 |
| EPS - Diluted | ₹2.44 | ₹13.26 | ₹20.52 | ₹44.59 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹7.58 | ₹43.57 | ₹44.78 | ₹104.12 |
| Income before WC changes | ₹36.89 | ₹72.17 | ₹61.47 | ₹114.08 |
| Change in Assets | -₹2.89 | ₹22.02 | -₹4.31 | -₹83.25 |
| Change in Liabilities | -₹4.83 | ₹12.42 | -₹20.09 | ₹7.95 |
| Change in WC | -₹7.72 | ₹34.44 | -₹24.40 | -₹75.30 |
| Cash flow from Operations | ₹24.67 | ₹98.04 | ₹27.78 | ₹20.38 |
| Cash flow from Investing | -₹65.25 | -₹120.54 | -₹101.14 | -₹196.81 |
| Cash flow from Financing | ₹16.57 | ₹30.52 | ₹37.80 | ₹234.96 |
| Total Cash Flow | -₹24.02 | ₹8.02 | -₹35.57 | ₹58.54 |
| Cash (Start of the year) | ₹35.30 | ₹27.37 | ₹63.02 | ₹4.48 |
| Cash (End of the year) | ₹11.37 | ₹35.30 | ₹27.37 | ₹63.02 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹571.00 | ₹520.81 | ₹446.61 | ₹222.42 |
| Current Assets | ₹265.25 | ₹297.91 | ₹312.25 | ₹435.89 |
| Total Assets | ₹836.25 | ₹818.72 | ₹758.86 | ₹658.30 |
| Current Liabilities | ₹96.03 | ₹79.66 | ₹238.69 | ₹171.43 |
| Net Current Asset | ₹169.22 | ₹218.24 | ₹73.56 | ₹264.45 |
| Non-Current Liabilities | ₹1.40 | ₹1.97 | ₹5.38 | ₹13.78 |
| Equity Capital | ₹738.82 | ₹737.08 | ₹514.79 | ₹473.09 |
| Total Equity & Liabilities | ₹836.25 | ₹818.72 | ₹758.86 | ₹658.30 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹366.42 | ₹378.68 | ₹403.04 | ₹427.81 |
| Other Income | ₹3.56 | ₹7.51 | ₹5.68 | ₹10.63 |
| Total Revenue | ₹369.98 | ₹386.19 | ₹408.72 | ₹438.44 |
| Total Expenses | ₹369.52 | ₹343.92 | ₹366.30 | ₹335.17 |
| Profit Before Tax | ₹0.46 | ₹42.27 | ₹38.83 | ₹103.27 |
| Tax | ₹0.13 | ₹12.92 | -₹1.63 | ₹7.28 |
| Profit After Tax | ₹0.33 | ₹29.35 | ₹40.47 | ₹95.99 |
| EPS - Basic | ₹0.14 | ₹12.82 | ₹18.26 | ₹44.65 |
| EPS - Diluted | ₹0.14 | ₹12.82 | ₹18.26 | ₹44.65 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹0.46 | ₹42.27 | ₹38.83 | ₹103.27 |
| Income before WC changes | ₹28.80 | ₹70.44 | ₹54.65 | ₹112.90 |
| Change in Assets | ₹6.40 | ₹24.54 | ₹14.02 | -₹108.39 |
| Change in Liabilities | -₹6.86 | ₹14.27 | -₹37.20 | ₹33.21 |
| Change in WC | -₹0.46 | ₹38.81 | -₹23.18 | -₹75.18 |
| Cash flow from Operations | ₹23.91 | ₹102.78 | ₹23.73 | ₹19.76 |
| Cash flow from Investing | -₹65.25 | -₹120.54 | -₹101.12 | -₹196.69 |
| Cash flow from Financing | ₹16.57 | ₹30.54 | ₹37.82 | ₹235.01 |
| Total Cash Flow | -₹24.78 | ₹12.78 | -₹39.58 | ₹58.05 |
| Cash (Start of the year) | ₹33.99 | ₹21.19 | ₹60.78 | ₹2.73 |
| Cash (End of the year) | ₹9.21 | ₹33.99 | ₹21.19 | ₹60.78 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹571.29 | ₹521.46 | ₹447.25 | ₹223.08 |
| Current Assets | ₹251.52 | ₹293.61 | ₹307.61 | ₹453.12 |
| Total Assets | ₹822.80 | ₹815.07 | ₹754.86 | ₹676.20 |
| Current Liabilities | ₹100.09 | ₹87.21 | ₹244.70 | ₹193.55 |
| Net Current Asset | ₹151.43 | ₹206.39 | ₹62.91 | ₹259.57 |
| Non-Current Liabilities | ₹1.40 | ₹1.97 | ₹5.38 | ₹13.77 |
| Equity Capital | ₹721.31 | ₹725.88 | ₹504.78 | ₹468.88 |
| Total Equity & Liabilities | ₹822.80 | ₹815.07 | ₹754.86 | ₹676.20 |
About Tatva Chintan Pharma Chem
Tatva Chintan Pharma Chem Limited is an India-based specialty chemical manufacturing company. The Company is engaged in the manufacturing of a variety of chemicals, including structure directing agents (SDAs), phase transfer catalysts (PTCs), electrolyte salts and solutions (ESS) for capacitor batteries, and pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC). Its SDAs are used for forming channels in zeolites. Its PTCs are used in heterogeneous multiphase systems, facilitating reactant migration. It operates through the Specialty chemical segment. The Company operates two manufacturing facilities situated at Ankleshwar and Dahej in Bharuch, Gujarat, India. It caters to various customers across various industries, including the automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances industries. The Company’s subsidiaries are Tatva Chintan Europe B.V. and Tatva Chintan USA Inc.
Tatva Chintan Pharma Chem Financial Highlights
- Revenue: Tatva Chintan Pharma Chem reported revenue of ₹509.41 crore in FY26 vs ₹385.03 crore in FY25. It showed an increase of 32.30% on a yearly basis.
- Operating Profit: Tatva Chintan Pharma Chem reported an operating profit of ₹57.01 crore in FY26 vs ₹7.58 crore in FY25. It showed an increase of 652.11% on a year-on-year basis.
- Net Profit: Tatva Chintan Pharma Chem reported a net profit of ₹42.05 crore in FY26 vs ₹5.71 crore in FY25. It showed an increase of 636.43% on a yearly basis.
Tatva Chintan Pharma Chem Quarterly Result Highlights
- Tatva Chintan Pharma Chem reported revenue of ₹133.79 crore in Mar 2026, compared with ₹133.06 crore in Dec 2025, representing an increase of 0.55% on a quarter-on-quarter (QoQ) basis.
- Tatva Chintan Pharma Chem reported an operating profit of ₹16.59 crore in Mar 2026, compared with ₹17.66 crore in Dec 2025, representing a decrease of 6.06% on a quarter-on-quarter (QoQ) basis.
- Tatva Chintan Pharma Chem reported a profit of ₹10.32 crore in Mar 2026, compared with ₹15.17 crore in Dec 2025, reflecting a decrease of 31.97% on a QoQ basis.
- The earnings per share (EPS) of Tatva Chintan Pharma Chem stood at ₹2.44 during Mar 2026.
Similar Stocks
FAQs on Tatva Chintan Pharma Chem Share Price
What is Tatva Chintan Pharma Chem share price today?
Tatva Chintan Pharma Chem share price is ₹1,245.00 as on 03 Jul, 2026, 15:29 IST.
How has the Tatva Chintan Pharma Chem share price performed in the past?
In the last 1 year, Tatva Chintan Pharma Chem delivered a return of 22.77%. The Tatva Chintan Pharma Chem share price hit a high of ₹1,610.00 and low of ₹919.75.
How much is the Mutual Fund shareholding in Tatva Chintan Pharma Chem shares?
The Mutual Fund Shareholding in Tatva Chintan Pharma Chem was 2.87% at the end of Mar 2026.
What is the the 52-week high and low of Tatva Chintan Pharma Chem shares ?
The 52-week high and low of Tatva Chintan Pharma Chem share is ₹1,610.00 and ₹919.75 as of 03 Jul, 2026.
What is the market cap of Tatva Chintan Pharma Chem?
The market capitalisation of Tatva Chintan Pharma Chem is ₹2,970.44 Crores as on 03 Jul, 2026.
What are the stock symbols of Tatva Chintan Pharma Chem?
The stock symbol of Tatva Chintan Pharma Chem is TATVA on the NSE, 543321 on the BSE, and the ISIN is INE0GK401011.
What was yesterday's closing price of Tatva Chintan Pharma Chem shares ?
Tatva Chintan Pharma Chem shares closed yesterday at ₹1,267.60 on NSE & ₹1,269.85 on BSE
How to buy Tatva Chintan Pharma Chem shares?
To buy Tatva Chintan Pharma Chem shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Tatva Chintan Pharma Chem shares on Holidays?
No, shares of Tatva Chintan Pharma Chem or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Tatva Chintan Pharma Chem shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Tatva Chintan Pharma Chem?
The PE and PB ratio of Tatva Chintan Pharma Chem is 70.63 and 3.8 respectively, as on 03 Jul, 2026, 15:29 IST.